Mise à jour des recommandations de la Société Européenne de Cardiologie : au sujet de la fibrillation auriculaire.

[en] The 2020 recommendations of the European Society of Cardiology have been enriched on the basis of numerous data published over the past 4 years. They emphasize the importance of a comprehensive management of the arrhythmia and give an increasingly prominent place to treatment by ablation. In this article, we summarize all the new recommendations.

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Pegnyemb, Mathurin ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de cardiologie

Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation

Language :

French

Title :

Mise à jour des recommandations de la Société Européenne de Cardiologie : au sujet de la fibrillation auriculaire.

Alternative titles :

[en] Recommendations update of the European Society of Cardiology about atrial fibrillation

Publication date :

2020

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

706-710

Peer reviewed :

Peer reviewed

Available on ORBi :

since 02 September 2021

Statistics

Number of views

320 (11 by ULiège)

Number of downloads

344 (12 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

See more details

Bibliography

Kulbertus H, Lancellotti P. La fibrillation auriculaire : une épidémie du troisième âge? Rev Med Liege 2014; 69:301-8.
Staerk L, Sherer JA, Ko D, et al. Atrial fibrillation : epidemiology, pathophysiology, clinical outcomes. Circ Res 2017; 120:1501-17.
Ganesan AN, Chew DP, Hartshorne T, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding : a systematic review and meta-analysis. Eur Heart J 2016; 37:1591-602.
Allan V, Honarbakhsh S, Casas JP, et al. Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? : a systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants. Thromb Haemost 2017; 117:837-50.
Aune D, Feng T, Schlesinger S, et al. Diabetes mellitus, blood glucose and the risk of atrial fibrillation : a systematic review and meta-analysis of cohort studies. J Diabetes Complications 2018; 32:501-11.
Cadby G, McArdle N, Briffa T, et al. Severity of OSA is an independent predictor of incident atrial fibrillation hospitalization in a large sleep-clinic cohort. Chest 2015; 148:945-52.
Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Hear J 2020; doi: 10.1093/ eurheartj/ehaa612.
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 2016; 18:1609-78.
Charitos EI, Stierle U, Ziegler PD, et al. A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions. Circulation 2012; 126:806-14.
Tomasdottir M, Friberg L, Hijazi Z, et al. Risk of ischemic stroke and utility of CHA2DS2-VASc score in women and men with atrial fibrillation. Clin Cardiol 2019; 42:1003-9.
Melon P, Lancellotti P. 2010 Recommandations européennes 2010 pour le traitement anti-thrombotique de la fibrillation auriculaire : nouveaux scores pour l'évaluation des risques d'accident vasculaire cérébral et de saignement. Rev Med Liege 2010; 65:580-2.
Chao TF, Liao JN, Tuan TC, et al. Incident co-morbidities in patients with atrial fibrillation initially with a CHA 2 DS 2 -VASc score of 0 (males) or 1 (females): implications for reassessment of stroke risk in initially "low-risk" patients. Thromb Haemost 2019; 119:1162-70.
Chao TF, Chiang CE, Chen TJ, et al. Reassessment of risk for stroke during follow-up of patients with atrial fibrillation. Ann Intern Med 2019; 170:663-4.
Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation : the Euro Heart Survey. Chest 2010; 138:1093-100.
Boriani G, Diemberger I, Biffi M, et al. Pharmacological cardioversion of atrial fibrillation : current management and treatment options. Drugs 2004; 64:2741-62
Al-Khatib SM, LaPointe NM, Chatterjee R, et al. Rate- and rhythm-control therapies in patients with atrial fibrillation : a systematic review. Ann Intern Med 2014; 160:760-73.
Voskoboinik A, Sparks PB, Morton JB, et al. Low rates of major complications for radiofrequency ablation of atrial fibrillation maintained over 14 years : a single centre experience of 2750 consecutive cases. Hear Lung Circ 2018; 27:976-83.
Lee G, Sparks PB, Morton JB, et al. Low risk of major complications associated with pulmonary vein antral isolation for atrial fibrillation : results of 500 consecutive ablation procedures in patients with low prevalence of structural heart disease from a single center. J Cardiovasc Electrophysiol 2011; 22:163-8.
Cardoso R, Knijnik L, Bhonsale A, et al. An updated meta-analysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablation. Heart Rhythm 2018; 15:107-15.
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37:2893-962.
Lafuente-Lafuente C, Longas-Tejero MA, Bergmann JF, Belmin J. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev 2012; 3:CD005049.
Rienstra M, Hobbelt AH, Alings M, et al. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation : results of the RACE 3 trial. Eur Heart J 2018; 39:2987-96.
Lip GY, Collet JP, Haude M, et al. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions : a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace 2019; 21:192-3.
Shen AY, Yao JF, Brar SS, et al. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol 2007; 50:309-15.
Page RL. Treatment of arrhythmias during pregnancy. Am Heart J 1995; 130:871-6.
Potpara TS, Marinkovic JM, Polovina MM, et al. Genderrelated differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart : the Belgrade atrial fibrillation study. Int J Cardiol 2012; 161:39-44

Similar publications

Sorry the service is unavailable at the moment. Please try again later.